Feedback / Questions
Bavencio (avelumab) - EMD Serono, Pfizer
Keytruda (pembrolizumab) - Merck (MSD)
MRx0518 - 4D Pharma
https://www.businesswire.com/news/home/20220331006021/en/4D-pharma-Reports-Full-Year-2021-Financial-Results-Operational-Highlights-and-Guidance-for-Key-Milestones-in-2022
Mar 31, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next